As I discussed last week, China — while still among the fastest-growing of the world’s largest economies — is going through some economic doldrums. Its GDP is expected to grow less than 7% in 2015, down from an average of 8.1% annually for the first four years of the decade. I told you last week about some of the industries, and a few specific companies, that have enormous exposure to China. If your portfolio is heavily leveraged on Chinese growth, you may want to pare back holdings in these areas. #-ad_banner-#Today, I’ll highlight another stock that has no exposure to… Read More
As I discussed last week, China — while still among the fastest-growing of the world’s largest economies — is going through some economic doldrums. Its GDP is expected to grow less than 7% in 2015, down from an average of 8.1% annually for the first four years of the decade. I told you last week about some of the industries, and a few specific companies, that have enormous exposure to China. If your portfolio is heavily leveraged on Chinese growth, you may want to pare back holdings in these areas. #-ad_banner-#Today, I’ll highlight another stock that has no exposure to China’s economy. A slowdown that’s worse than expected over there will have no impact on this all-American gem’s bottom line. Before I get to the specific recommendation, consider the parts of our economy that don’t do much business with China — either by selling goods and services to China’s huge, growing middle class or by taking advantage of Chinese manufacturing plants. The most obvious such area is a service provider focused solely on U.S. customers. For example, most hospital and home healthcare companies have little overseas exposure other than in Canada; Kindred Healthcare (NYSE: KND) is a prominent example. And… Read More